Global Tenodesis Devices Market Size By Type (Arthroscopic Biceps Tendon Repair, Open Biceps Tendon Repair), By Application (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts,...

The Global Tenodesis Devices Market was valued at USD 180 million in 2023 and is projected to surpass USD 310 million by 2031, expanding at a CAGR of 7.0% during the forecast period of 2023-2031. The market growth is driven by the increasing prevalence of orthopedic injuries, rising geriatric population, advancements in surgical procedures, and growing sports-related injuries globally. Tenodesis devices are extensively used in orthopedic surgeries for tendon fixation, primarily in procedures involving shoulder, knee, and ankle injuries.

The increasing demand for minimally invasive surgical procedures and the availability of bioabsorbable tenodesis devices are further contributing to the market expansion. Furthermore, the surge in outpatient surgical centers and technological innovations in orthopedic implants provide favorable conditions for the growth of this market.

Drivers:

Rising Incidence of Orthopedic and Sports Injuries:

Increasing musculoskeletal disorders, sports injuries, and orthopedic conditions, such as rotator cuff tears, are fueling the demand for tenodesis devices worldwide.

Growing Preference for Minimally Invasive Surgeries:

Minimally invasive procedures offer faster recovery, reduced hospital stays, and less postoperative pain, driving the adoption of advanced tenodesis devices.

Technological Advancements in Tenodesis Devices:

Continuous innovation in bioabsorbable materials and device design enhances the performance and safety of tenodesis devices, boosting market growth.

Restraints:

High Cost of Surgical Procedures:

The high cost associated with orthopedic surgeries, including tenodesis procedures, may hinder the market's growth, especially in low-income regions.

Risk of Postoperative Complications:

Despite advancements, potential complications such as infection, implant failure, or improper tendon fixation pose challenges to market expansion.

Opportunity:

Expansion in Emerging Economies:

Emerging markets like Asia-Pacific and Latin America offer significant growth opportunities due to improving healthcare infrastructure and increasing healthcare spending.

Increasing Focus on Outpatient and Ambulatory Surgery Centers:

The growth of outpatient surgical centers, which offer cost-effective and faster treatment, provides new opportunities for the tenodesis devices market.

Market by System Type Insights:

Based on system type, the Bioabsorbable Tenodesis Devices segment dominated the market in 2023 due to its advantages such as reduced implant removal surgeries, biocompatibility, and enhanced healing properties. The Metallic Tenodesis Devices segment, although traditional, remains widely used due to its durability and mechanical strength.

Market by End-use Insights:

By end-use, the Hospitals segment accounted for the largest revenue share in 2023, supported by a higher volume of orthopedic surgeries conducted in hospital settings. However, the Ambulatory Surgical Centers (ASCs) segment is anticipated to witness the fastest growth rate during the forecast period, owing to rising demand for cost-effective and minimally invasive procedures.

Market by Regional Insights:

North America held the largest market share in 2023, driven by the high prevalence of sports injuries, advanced healthcare infrastructure, and significant presence of leading market players. The Asia-Pacific region is projected to experience the highest growth rate during the forecast period due to increasing healthcare expenditure, rising medical tourism, and a growing geriatric population.

Competitive Scenario:

Leading players in the Global Tenodesis Devices Market include:

Arthrex, Inc.

Smith & Nephew plc

Stryker Corporation

Johnson & Johnson (DePuy Synthes)

Zimmer Biomet Holdings, Inc.

Parcus Medical, LLC

CONMED Corporation

Wright Medical Group N.V.

Key strategies adopted by these players include product innovation, strategic collaborations, mergers & acquisitions, and geographical expansion to strengthen their market presence.

Scope of Work – Global Tenodesis Devices Market

Report Metric Details

Market Size (2023) USD 180 million

Projected Market Size (2031) USD 310 million

CAGR (2023-2031) 7.0%

Key Segments System Type (Bioabsorbable, Metallic), End-use (Hospitals, ASCs, Specialty Clinics), Region

Growth Drivers Rising orthopedic injuries, growing adoption of minimally invasive procedures, technological advancements in devices

Opportunities Expansion in emerging markets, increasing focus on outpatient surgical centers

Key Market Developments:

In 2023, Arthrex, Inc. launched an advanced bioabsorbable tenodesis device designed to offer enhanced fixation strength and faster healing.

In 2024, Stryker Corporation announced a strategic collaboration with sports medicine clinics to promote its latest tenodesis device portfolio.

In 2025, Smith & Nephew plc expanded its orthopedic manufacturing facility in the Asia-Pacific region to meet the growing demand for tenodesis devices.

FAQs:

1) What is the current market size of the Global Tenodesis Devices Market?

The Global Tenodesis Devices Market was valued at USD 180 million in 2023.

2) What is the major growth driver of the Global Tenodesis Devices Market?

The rising prevalence of orthopedic injuries and increasing demand for minimally invasive surgeries are the major growth drivers of the market.

3) Which is the largest region during the forecast period in the Global Tenodesis Devices Market?

North America is the largest region during the forecast period due to its advanced healthcare infrastructure and high incidence of orthopedic conditions.

4) Which segment accounted for the largest market share in the Global Tenodesis Devices Market?

The Bioabsorbable Tenodesis Devices segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Tenodesis Devices Market?

Key market players include Arthrex, Inc., Smith & Nephew plc, Stryker Corporation, Johnson & Johnson (DePuy Synthes), Zimmer Biomet Holdings, Inc., Parcus Medical, LLC, CONMED Corporation, and Wright Medical Group N.V.